Effect of alpha-tocopheryl succinate on the molecular damage induced by indomethacin in C6 glioma cells

Pekmez M., Onay-Ucar E., Arda N.

EXPERIMENTAL AND THERAPEUTIC MEDICINE, vol.9, no.2, pp.585-590, 2015 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 9 Issue: 2
  • Publication Date: 2015
  • Doi Number: 10.3892/etm.2014.2101
  • Journal Name: EXPERIMENTAL AND THERAPEUTIC MEDICINE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.585-590
  • Keywords: alpha-tocopheryl succinate, indomethacin, C6 Glioma, intracellular ROS level, protein carbonyls, NONSTEROIDAL ANTIINFLAMMATORY DRUGS, VITAMIN-E, CYCLOOXYGENASE-2 EXPRESSION, PROGNOSTIC-SIGNIFICANCE, GENE-EXPRESSION, IN-VIVO, GROWTH, CANCER, INHIBITION, ASPIRIN
  • Istanbul University Affiliated: Yes

Abstract

Indomethacin is a member of the non-steroidal anti-inflammatory drug (NSAID) class, which has great potential for use in the treatment of glioma. However, it induces the generation of reactive oxygen species (ROS) and causes molecular damage while inducing its effects. Vitamin E is widely used in the complementary therapy of cancers. The main goal of the present study was to investigate the effects of alpha-tocopheryl succinate (alpha-TOS) against the oxidative damage induced by indomethacin in C6 glioma cells. Cells were treated with 10 piM alpha-TOS alone or in combination with 200 piM indomethacin for two days. The intracellular ROS level, molecular damage as revealed by lipid peroxidation and protein carbonyl formation, and the COX activity in C6 glioma cells were measured. Treatment of the cells with alpha-TOS and indomethacin, alone or in combination, caused the levels of ROS generation and protein damage to increase, but protected against lipid peroxidation and reduced COX activity.